XMT-1660: A phase I, first-in-human trial of a B7-H4-directed dolasynthen antibody-drug conjugate in ovarian, endometrial, and breast cancers Meeting Abstract
| Authors: | Burger, R.; Hamilton, E.; Adams, S.; Han, H.; Spira, A.; Giordano, A.; Chaudhry, A.; Parajuli, R.; Wang, J.; Weise, A.; Abuhadra, N.; McNamara, P.; Kalinsky, K. |
| Abstract Title: | XMT-1660: A phase I, first-in-human trial of a B7-H4-directed dolasynthen antibody-drug conjugate in ovarian, endometrial, and breast cancers |
| Meeting Title: | Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer |
| Journal Title: | Gynecologic Oncology |
| Volume: | 190 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Mar 15-18 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-11-01 |
| Start Page: | S282 |
| Language: | English |
| ACCESSION: | WOS:001330731400406 |
| DOI: | 10.1016/j.ygyno.2024.07.418 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2119 [TIP] -- Source: Wos |
